- Home
- NVCT vs SBI Comparison
NVCT vs SBI Comparison
Compare NVCT & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- SBI
- Stock Information
- Founded
- NVCT 2020
- SBI 1992
- Country
- NVCT United States
- SBI United States
- Employees
- NVCT N/A
- SBI N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- SBI Finance/Investors Services
- Sector
- NVCT Health Care
- SBI Finance
- Exchange
- NVCT Nasdaq
- SBI Nasdaq
- Market Cap
- NVCT 170.3M
- SBI 111.3M
- IPO Year
- NVCT 2022
- SBI N/A
- Fundamental
- Price
- NVCT $9.49
- SBI $7.83
- Analyst Decision
- NVCT Strong Buy
- SBI
- Analyst Count
- NVCT 3
- SBI 0
- Target Price
- NVCT $15.67
- SBI N/A
- AVG Volume (30 Days)
- NVCT 131.5K
- SBI 39.5K
- Earning Date
- NVCT 05-06-2025
- SBI 01-01-0001
- Dividend Yield
- NVCT N/A
- SBI 4.52%
- EPS Growth
- NVCT N/A
- SBI N/A
- EPS
- NVCT N/A
- SBI N/A
- Revenue
- NVCT N/A
- SBI N/A
- Revenue This Year
- NVCT N/A
- SBI N/A
- Revenue Next Year
- NVCT N/A
- SBI N/A
- P/E Ratio
- NVCT N/A
- SBI N/A
- Revenue Growth
- NVCT N/A
- SBI N/A
- 52 Week Low
- NVCT $4.44
- SBI $6.96
- 52 Week High
- NVCT $11.80
- SBI $8.00
- Technical
- Relative Strength Index (RSI)
- NVCT 55.68
- SBI 50.00
- Support Level
- NVCT $9.00
- SBI $7.75
- Resistance Level
- NVCT $10.71
- SBI $7.90
- Average True Range (ATR)
- NVCT 0.97
- SBI 0.05
- MACD
- NVCT -0.02
- SBI 0.00
- Stochastic Oscillator
- NVCT 40.63
- SBI 58.18
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About SBI Western Asset Intermediate Muni Fund Inc
Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.